Live Breaking News & Updates on Stewart Holmstrom

Stay updated with breaking news from Stewart holmstrom. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Presentation to J.P. Morgan Healthcare Conference and Q4 2022 Illuccix Revenue Update

/PRNewswire/ Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today advises it is presenting at the 41st Annual J.P. Morgan Healthcare. ....

United States , United Kingdom , San Francisco , Kyahn Williamson , Stewart Holmstrom , Christian Behrenbruch , Telix Pharmaceuticals , Drug Administration , Australian Securities Exchange , Australian Therapeutic Goods Administration , Prnewswire Telix Pharmaceuticals Limited , Corporate Communications , Health Canada , Pharmaceuticals Limited , Healthcare Conference , Managing Director , Group Chief Executive , Telix Pharmaceuticals Limited ,

Presentation to J.P. Morgan Healthcare Conference and Q4 2022 Illuccix Revenue Update

/PRNewswire/ Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today advises it is presenting at the 41st Annual J.P. Morgan Healthcare. ....

United States , United Kingdom , San Francisco , Kyahn Williamson , Stewart Holmstrom , Christian Behrenbruch , Telix Pharmaceuticals , Drug Administration , Australian Securities Exchange , Australian Therapeutic Goods Administration , Prnewswire Telix Pharmaceuticals Limited , Corporate Communications , Health Canada , Pharmaceuticals Limited , Healthcare Conference , Managing Director , Group Chief Executive , Telix Pharmaceuticals Limited , Health Care Amp Hospitals , Medical Pharmaceuticals , Pharmaceuticals , Conference Call Announcements ,

Telix Pharmaceuticals Limited: Presentation to J.P. Morgan Healthcare Conference and Q4 2022 Illuccix Revenue Update

MELBOURNE, Australia, Jan. 8, 2023 /PRNewswire/ Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today advises it is presenting at the 41st Annual J.P. Morgan Healthcare Conference ....

United States , United Kingdom , San Francisco , Kyahn Williamson , Stewart Holmstrom , Christian Behrenbruch , Telix Pharmaceuticals , Drug Administration , Australian Securities Exchange , Australian Therapeutic Goods Administration , Prnewswire Telix Pharmaceuticals Limited , Corporate Communications , Health Canada , Pharmaceuticals Limited , Healthcare Conference , Managing Director , Group Chief Executive Officer , Telix Pharmaceuticals Limited ,

Presentation to J.P. Morgan Healthcare Conference and Q4 2022 Illuccix Revenue Update

MELBOURNE, Australia, Jan. 8, 2023 /PRNewswire/ Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today advises it is presenting at . ....

United States , United Kingdom , San Francisco , Kyahn Williamson , Stewart Holmstrom , Christian Behrenbruch , Telix Pharmaceuticals , Drug Administration , Australian Securities Exchange , Australian Therapeutic Goods Administration , Prnewswire Telix Pharmaceuticals Limited , Corporate Communications , Health Canada , Pharmaceuticals Limited , Healthcare Conference , Managing Director , Group Chief Executive , Telix Pharmaceuticals Limited ,

Presentation to J.P. Morgan Healthcare Conference and Q4 2022 Illuccix Revenue Update

/PRNewswire/ Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today advises it is presenting at the 41st Annual J.P. Morgan Healthcare. ....

United States , United Kingdom , San Francisco , Kyahn Williamson , Stewart Holmstrom , Christian Behrenbruch , Telix Pharmaceuticals , Drug Administration , Australian Securities Exchange , Australian Therapeutic Goods Administration , Prnewswire Telix Pharmaceuticals Limited , Corporate Communications , Health Canada , Pharmaceuticals Limited , Healthcare Conference , Managing Director , Group Chief Executive , Telix Pharmaceuticals Limited ,